Activation of cytomegalovirus-specific CD8(+) T-cell response by antibody-mediated peptide-major histocompatibility class I complexes

Imposing antigenicity on tumor cells is a key step toward successful cancer-immunotherapy. A cytomegalovirus-derived peptide recombinantly fused to a major histocompatibility class I complex and a monoclonal antibody can be targeted to tumor cells by antibody-mediated delivery and activate a strong...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmittnaegel, Martina, Klein, Christian, Levitsky, Victor, Knoetgen, Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760341/
https://www.ncbi.nlm.nih.gov/pubmed/26942061
http://dx.doi.org/10.1080/2162402X.2015.1052930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760341/
https://www.ncbi.nlm.nih.gov/pubmed/26942061
http://dx.doi.org/10.1080/2162402X.2015.1052930

Ejemplares similares